MYDA Advisors’s iShares Biotechnology ETF IBB Stock Holding History

MYDA Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,000	Closed	-$633K	–	185
2025 Q2	$633K	Sell	5,000 -5,000	-50%	-$614K	0.11%	110
2025 Q1	$1.28M	Buy	+10,000	New	+$1.36M	0.22%	76
2024 Q1	–	Sell	-8,000	Closed	-$1.09M	–	135
2023 Q4	$1.09M	Sell	8,000 -39,000	-83%	-$4.76M	0.36%	50
2023 Q3	$5.75M	Buy	+47,000	New	+$5.98M	1.86%	18
2022 Q3	–	Sell	-16,000	Closed	-$1.88M	–	179
2022 Q2	$1.88M	Sell	16,000 -2,000	-11%	-$237K	0.53%	51
2022 Q1	$2.35M	Buy	+18,000	New	+$2.34M	0.93%	35
2020 Q2	–	Sell	-4,000	Closed	-$431K	–	137
2020 Q1	$431K	Buy	+4,000	New	+$461K	0.27%	81

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MYDA Advisors's IBB Position: Q3 2025 in Review

MYDA Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 5,000 shares — an estimated $633K sold.

MYDA Advisors first reported a position in IBB in Q1 2020 and held it in 7 quarters. The position peaked at $5.75M in Q3 2023. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

MYDA Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
MYDA Advisors sold 5,000 iShares Biotechnology ETF shares in Q3 2025, an estimated $633K.
MYDA Advisors first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 7 quarters.
MYDA Advisors's iShares Biotechnology ETF position peaked at $5.75M in Q3 2023.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on MYDA Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.